NCT07637474

Immune Metabolism Dysregulation and Efficacy to Anti-PD-1 PD-L1 Agents in Non Small Cell Lung Cancer Patients

RecruitingOBSERVATIONAL

Trial Details

Start: 2024-07-24Est. Completion: 2026-07-24

Enrollment target: 150 participants

Locations

Contact

Metastatic Non-Squamous Non-Small Cell Lung CancerAdult Solid Tumor

This is an exploratory, signal-finding, randomized, placebo-controlled, blinded, multi-center phase 2b trial of the anti…

Birmingham, United StatesEst. completion Oct 1, 2029

Non-small Cell Lung Cancer

This trial will evaluate the efficacy and safety of various therapies in participants with Stage IB, IIA, IIB, IIIA, or …

Duarte, United StatesEst. completion Nov 30, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.